Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Lactobacillus Crispatus in NLUTD
NCT07308808Phase 1Recruiting
- Sponsor
- MedStar Health Research Institute
- Start
- Sep 2025
- Primary completion
- Mar 2027
- Modality
- Bacterial Strains
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lactobacillus crispatus in urinary tract infection (UTI) and neurogenic bladder (2 arms), sponsored by MedStar Health Research Institute. Primary endpoints: Urinary Symptom Questionnaire for Neurogenic Bladder-Intermittent Catheter and 16S rRNA gene sequencing. Started Sep 2025; status: recruiting.
02
Drugs
lactobacillus crispatus
03
Conditions
urinary tract infection (UTI)neurogenic bladder
Beyond the preview
Go deeper on NCT07308808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07308808.